Interland Announces Earnings Release Date and Conference Call
October 20, 2005 08:30 ET
|
Web.com, Inc.
ATLANTA, Oct. 20, 2005 (PRIMEZONE) -- Interland (Nasdaq:INLD), a leading provider of websites and online services for small and medium-sized businesses, today announced that it will report results...
Manhattan Pharmaceuticals to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
October 20, 2005 08:29 ET
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 20, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will be presenting at the C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference on Tuesday, October 25th at...
AllPennyStocks.com Spotlights T-Bay Holdings, Inc.
October 20, 2005 08:01 ET
|
AllPennyStocks.com Media Inc.
MISSISSAUGA, Ontario, Oct. 20, 2005 (PRIMEZONE) -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com), a leading penny stock/small-cap information site, released its latest spotlight...
Dime Community Bancshares Reports Third Quarter 2005 Earnings
October 20, 2005 08:00 ET
|
Dime Community Bancshares, Inc.
BROOKLYN, NY -- (MARKET WIRE) -- October 20, 2005 -- Dime Community Bancshares, Inc. (NASDAQ: DCOM)
(the "Company"), the parent company of The Dime Savings Bank of
Williamsburgh (the "Bank"), today...
VioQuest to Present at C.E. Unterberg, Towbin Emerging Growth Life Sciences Conference
October 20, 2005 08:00 ET
|
VioQuest Pharmaceuticals
MONMOUTH JUNCTION, N.J., Oct. 20, 2005 (PRIMEZONE) -- VioQuest Pharmaceuticals, Inc. (OTCBB:VQPH) has accepted an invitation to speak at the C.E. Unterberg, Towbin Emerging Growth Life Sciences...
Ringo Introduces 'Cost by Radius' Advertising Model
October 20, 2005 08:00 ET
|
Ringo Inc.
BOCA RATON, Fla., Oct. 20, 2005 (PRIMEZONE) -- Ringo, Inc. (Pink Sheets:RGOI) is pleased to introduce a patent pending proximity based advertising model to its location based service offerings....
UCB Confirms Good Performance of Zyrtec in U.S. and Xyzal
October 20, 2005 07:56 ET
|
UCB
BRUSSELS, Belgium, Oct. 20, 2005 (PRIMEZONE) -- Following Pfizer's quarterly earnings release, UCB confirms that Zyrtec continues to strengthen its leadership position as the number one most...
UCB bevestigt de goede prestatie van Zyrtec in de Verenigde Staten en van Xyzal
October 20, 2005 07:45 ET
|
UCB
Brussel, 20 oktober 2005 - Naar aanleiding van de mededeling van Pfizer, aangaande haar resultaten voor het derde trimester in 2005, bevestigt UCB de versterkte leiderspositie van Zyrtec als meest...
UCB confirme la bonne performance du Zyrtec aux USA et du Xyzal
October 20, 2005 07:45 ET
|
UCB
Bruxelles, Belgique - 20 octobre 2005 - Suite à l'annonce des résultats de Pfizer pour le troisième trimestre, UCB confirme que le Zyrtec continue à renforcer sa position de leader comme...
UCB confirms good performance of Zyrtec in US and Xyzal
October 20, 2005 07:45 ET
|
UCB
Brussels, BELGIUM - October 20, 2005 - Following Pfizer's quarterly earnings release, UCB confirms that Zyrtec continues to strengthen its leadership position as the number one most prescribed branded...